SPIRIT OF MUMBAI

 Ranveer Singh’s Official spokesperson shares, “Ranveer Singh holds the highest regard for the film fraternity and for everyone associated with the Don franchise. Throughout the recent developments surrounding Don 3, he has consciously chosen to maintain silence, believing that professional discussions and personal equations are best handled with dignity, maturity and mutual respect. While several narratives and speculations have surfaced over time, Ranveer has never considered it necessary to respond publicly or contribute to conjecture. His focus remains firmly on his work and the commitments ahead. He continues to hold deep respect and goodwill for all those involved and sincerely wishes the franchise continued success. Choosing restraint and grace in moments like these has always been a conscious decision on his part, and he will continue to maintain the same stance “

(L to R) Shri Sanjay Lohiya, Special Secretary, Department of Financial Services, Smt. Nirmala Sitharaman, The Hon’ble Union Minister for Finance and Corporate Affairs & Shri Manoj Mittal, Chairman & Managing Director, SIDBI SIDBI’s 37 th Foundation Day Celebrations National, 25 th May 2026: Smt. Nirmala Sitharaman, The Hon’ble Union Minister for Finance and Corporate Affairs, speaking at the 37th Foundation Day Celebrations event of Small Industries Development Bank of India (SIDBI) today in Mumbai said that the MSME sector remains central to India’s growth trajectory, employment generation, and export competitiveness. Hon’ble Finance Minister also highlighted various measures taken by the Govt of India for the sectors affected by West Asia War situation, including ECLGS 5.0 which will also support MSMEs in these difficult times. Hon’ble Finance Minister also outlined the vision for SIDBI and its role as market-maker, especially with regard to the capital infusion of Rs.5000...

• Breakthrough data from Immuneel Therapeutics shows sustained remission in multiple patients treated with Varnimcabtagene autoleucel (IMN-003A) • Seven patients surpass two-year progression-free survival (PFS), a national first known for Indian CAR T therapy • Benchmark response rates recorded with 83% ORR at Day 90 and 50% at Day 365 • Over 100 patients in the real world treated to date with improved outcomes and a favorable safety profile Bengaluru, 22 May 2026: In a major milestone in Indian oncology care, Immuneel Therapeutics’ Made-In-India CAR T-cell therapy has delivered the country’s first known long-term remission in patients with aggressive blood cancers. Seven patients treated in 2022 have now surpassed two years of progression-free survival (PFS), a first for any made-in-India CAR T-cell therapy. This achievement reinforces the durability of Immuneel’s approach and its potential to transform outcomes for patients with aggressive blood cancers.   The CAR T-cell ...

Performance UPDATE for the Year ended March 31st, 2026 (FY 2026)   v    Profit After Tax at Rs.57,419 crores, an increase of 19.25% Year on Year v    Board recommends final dividend of Rs.10/- per equity share of Rs. 10/- each (equivalent to Rs. 20/- per equity share pre-bonus issue basis) v    Individual Business Non-Par APE increased by 43.78% to Rs.15,214 crore. v    Non-Par APE share within Individual Business at 35.11% for FY26 as compared to 27.69% for FY25. v    Value of New Business (VNB) increased by 41.63% to Rs.14,179 crore. v    VNB Margin (Net) increased by 360 bps to 21.2% v    New Business Premium Income (Individual) increased by 8.29% to Rs.67,676 crore. v    Total Group Business Premium Income increased by 16.26% to Rs.1,96,609 crore. v    Total Premium Income increased by 9.80% to Rs.5,35,984 crore. v    Indian Embedded Value (IEV) increases by 1.58% to Rs.7,89,185 ...

Key Highlights : ·         Flexibility to choose from two Regular income options - starting immediately or deferred by 10 years ·         Steady income up to the age of 100 ·         Guaranteed Benefit Plus Terminal Bonus, if any at Maturity  ·         Equity exposure enabli ng long-term wealth creation ·         Goal Protection Benefit to continue policy benefits for the nominee on life assured’s death   Mumbai, May20 , 2026: IndiaFirst Life Insurance Company Ltd. (IndiaFirst Life), today announced the launch of IndiaFirst Life GOLD Plus Plan , a non-linked, participating, individual life insurance savings plan. Designed for customers across life stages, the IndiaFirst Life GOLD Plus Plan supports savings, and income needs while helping plan for children’s education, retirement, and other life goals ...

 As one of India’s leading real estate developers, Tata Realty and Infrastructure Ltd. is leveraging Salesforce’s Agentforce to deliver round-the-clock customer service and real-time intelligence -        First response times reduced from days to 8 hours; with email open rates rising to 50–60% *Mumbai, 19 May 2026* — TATA Realty & Infrastructure Ltd. (TRIL), a premier subsidiary of Tata Sons, and Salesforce, the world’s #1 AI CRM*,  have today announced the successful deployment of Salesforce’s Agentforce platform to transform customer engagement across TRIL’s portfolio. The implementation has significantly enhanced responsiveness, reducing first response times from days to just 8 hours, while enabling the company to manage thousands of customer interactions simultaneously. The transformation has delivered measurable business results with a 10% increase in conversion rates, 30% boost in lead qualification, and 50-60% email open rates, demonstrating how ...